Eden Research (LON:EDEN) Announces Quarterly Earnings Results

Eden Research (LON:EDEN) issued its earnings results on Wednesday. The company reported GBX (0.36) earnings per share for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.

Eden Research Stock Down 1.4%

LON:EDEN opened at GBX 2.17 on Thursday. The company has a debt-to-equity ratio of 1.43, a current ratio of 2.25 and a quick ratio of 2.42. Eden Research has a 1-year low of GBX 1.96 and a 1-year high of GBX 5. The company has a 50-day moving average of GBX 2.72 and a 200 day moving average of GBX 3.16. The firm has a market cap of £17.43 million, a PE ratio of -4.90 and a beta of 1.57.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.